tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

AU:PAR

Paradigm Biopharma Advances Phase 3 Trials Amid Financial Prudence
Company AnnouncementsParadigm Biopharma Advances Phase 3 Trials Amid Financial Prudence
10d ago
Paradigm Biopharmaceuticals Advances Phase 3 Trial Plans
PremiumCompany Announcements
Paradigm Biopharmaceuticals Advances Phase 3 Trial Plans
10d ago
Paradigm Biopharmaceuticals Plans New Securities Issuance
PremiumCompany Announcements
Paradigm Biopharmaceuticals Plans New Securities Issuance
17d ago
Paradigm Biopharmaceuticals Director Adjusts Holdings
PremiumCompany Announcements
Paradigm Biopharmaceuticals Director Adjusts Holdings
18d ago
Paradigm Biopharmaceuticals: Director Increases Shareholdings
PremiumCompany Announcements
Paradigm Biopharmaceuticals: Director Increases Shareholdings
18d ago
Paradigm Biopharmaceuticals Boosts Confidence with Phase 3 Plans
PremiumCompany AnnouncementsParadigm Biopharmaceuticals Boosts Confidence with Phase 3 Plans
20d ago
Paradigm Biopharmaceuticals Schedules Hybrid Annual Meeting
Premium
Company Announcements
Paradigm Biopharmaceuticals Schedules Hybrid Annual Meeting
23d ago
Paradigm Biopharmaceuticals Director Increases Shareholding
Premium
Company Announcements
Paradigm Biopharmaceuticals Director Increases Shareholding
25d ago
Paradigm Biopharmaceuticals Sets Date for AGM
PremiumCompany Announcements
Paradigm Biopharmaceuticals Sets Date for AGM
2M ago
Paradigm Biopharma Lists New Shares on ASX
PremiumCompany Announcements
Paradigm Biopharma Lists New Shares on ASX
2M ago
Paradigm Biopharmaceuticals Embraces Corporate Governance
PremiumCompany Announcements
Paradigm Biopharmaceuticals Embraces Corporate Governance
2M ago
Paradigm Biopharma Reports Revenue Decline and Losses
PremiumCompany Announcements
Paradigm Biopharma Reports Revenue Decline and Losses
2M ago
Paradigm Biopharma Advances Clinical Trials with Fiscal Prudence
PremiumCompany AnnouncementsParadigm Biopharma Advances Clinical Trials with Fiscal Prudence
3M ago
Paradigm Biopharmaceuticals Seeks New ASX Quotation
Premium
Company Announcements
Paradigm Biopharmaceuticals Seeks New ASX Quotation
6M ago
PAR
Paradigm Biopharmaceuticals Advances Clinical Programs
Premium
Company Announcements
Paradigm Biopharmaceuticals Advances Clinical Programs
6M ago
Paradigm Biopharma Conducts Share Buy-back
PremiumCompany Announcements
Paradigm Biopharma Conducts Share Buy-back
7M ago
Paradigm Submits Phase 3 OA Program to FDA
PremiumCompany Announcements
Paradigm Submits Phase 3 OA Program to FDA
7M ago
Paradigm Bio Cancels Shares in Buy-Back Scheme
PremiumCompany Announcements
Paradigm Bio Cancels Shares in Buy-Back Scheme
7M ago
Megaport (ASX:MP1) makes the “Perfect 10” Smart Score list
PremiumStock Analysis & Ideas
Megaport (ASX:MP1) makes the “Perfect 10” Smart Score list
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >